5-Fluorouracil and Cisplatin (FP) with Concurrent Radiotherapy for Locally Advanced Head and Neck Cancer

Cancer Research and Treatment ◽

10.4143/crt.2002.34.4.296 ◽

2002 ◽

Vol 34 (4) ◽

pp. 296-301 ◽

Author(s):

Hyoung Sam Kim ◽

Ki Seok Kim ◽

Sang Seok Bea ◽

Seok Jin Oh ◽

Ki Hyeong Lee ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Download Full-text

A retrospective study of induction chemotherapy with docetaxel, cisplatinum, and 5-fluorouracil followed by concurrent radiotherapy with cetuximab in locally advanced head and neck cancer

American Journal of Otolaryngology ◽

10.1016/j.amjoto.2011.02.004 ◽

2012 ◽

Vol 33 (1) ◽

pp. 93-97 ◽

Author(s):

Brian Kim ◽

Robert O. Dillman ◽

Peter Chen ◽

Russell Hafer ◽

Craig Cox ◽

...

Keyword(s):

Head And Neck Cancer ◽

Retrospective Study ◽

Head And Neck ◽

Induction Chemotherapy ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Download Full-text

Study of induction docetaxel, cisplatin, cetuximab and bevacizumab (TPE-A) followed by concurrent radiotherapy, cisplatin, cetuximab and bevacizumab (XPE-A) in patients with high-risk locally advanced head and neck cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.e22004 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. e22004-e22004

Author(s):

Grace M. Akinyi-Joseph ◽

Ahmad Mouhamad Wehbe ◽

Athanassios Argiris

Keyword(s):

Head And Neck Cancer ◽

High Risk ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Download Full-text

Interim Report of a Phase II Study of Lapatinib and Concurrent Radiotherapy in Patients With Locally Advanced Head and Neck Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2011.06.831 ◽

2011 ◽

Vol 81 (2) ◽

pp. S535

Author(s):

B. Bavan ◽

T. Krakow ◽

H. Pinto ◽

P. Harari ◽

D. Brizel ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Phase Ii ◽

Neck Cancer ◽

Phase Ii Study ◽

Locally Advanced ◽

Advanced Head ◽

Interim Report ◽

Concurrent Radiotherapy

Download Full-text

Faculty Opinions recommendation of Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14267332.15779532 ◽

2012 ◽

Author(s):

Ricardo Hitt

Keyword(s):

Head And Neck Cancer ◽

Protein Expression ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Predictive Biomarkers ◽

Advanced Head ◽

Fish Protein ◽

Concurrent Radiotherapy ◽

Mutational Status

Download Full-text

Concurrent radiotherapy and chemotherapy in the treatment of locally advanced head and neck cancer

European Journal of Cancer ◽

10.1016/s0959-8049(01)80871-6 ◽

2001 ◽

Vol 37 ◽

pp. S105

Author(s):

G. Arcangeli ◽

B. Saracino ◽

D. Tirindelli Danesi ◽

G. Giovinazzo ◽

F. Cognetti ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Download Full-text

Gefitinib, cisplatin, and concurrent radiotherapy for locally advanced head and neck cancer: EGFR FISH, protein expression, and mutational status are not predictive biomarkers

Annals of Oncology ◽

10.1093/annonc/mdr327 ◽

2012 ◽

Vol 23 (4) ◽

pp. 1010-1016 ◽

Author(s):

E.-H. Tan ◽

C. Goh ◽

W.T. Lim ◽

K.C. Soo ◽

M.L. Khoo ◽

...

Keyword(s):

Head And Neck Cancer ◽

Protein Expression ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Predictive Biomarkers ◽

Advanced Head ◽

Fish Protein ◽

Concurrent Radiotherapy ◽

Mutational Status

Download Full-text

Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer

Oral Oncology ◽

10.1016/j.oraloncology.2015.04.012 ◽

2015 ◽

Vol 51 (7) ◽

pp. 704-708 ◽

Author(s):

Tobin J. Strom ◽

Andy M. Trotti ◽

Julie Kish ◽

Jeffery S. Russell ◽

Nikhil G. Rao ◽

...

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Advanced Head ◽

Concurrent Radiotherapy

Download Full-text

Phase I study of weekly docetaxel (T), cisplatin (P) with daily celecoxib (C) and concurrent radiotherapy (RT) for patients with locally advanced head and neck cancer (HNC)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.5598 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 5598-5598 ◽

Author(s):

R. S. Axelrod ◽

M. Machtay ◽

P. R. Anne ◽

A. Dicker ◽

K. Sidhu ◽

...

Keyword(s):

Head And Neck Cancer ◽

Phase I ◽

Head And Neck ◽

Neck Cancer ◽

Phase I Study ◽

Locally Advanced ◽

Advanced Head ◽

Weekly Docetaxel ◽

Concurrent Radiotherapy

Download Full-text

The Role of Chemoradiotherapy in Treatment of Patients with Locally Advanced Head and Neck Cancer

Ukraïnsʹkij žurnal medicini bìologìï ta sportu ◽

10.26693/jmbs03.04.115 ◽

2018 ◽

Vol 3 (4) ◽

pp. 115-119

Author(s):

M. V. Sadchikova ◽

Keyword(s):

Head And Neck Cancer ◽

Head And Neck ◽

Neck Cancer ◽

Locally Advanced ◽

Download Full-text

An Experimental Study to Compare Treatment Response and Toxicities of Concurrent Chemoradiation With Weekly Cisplatin and Three Weekly Cisplatin in Locally Advanced Head and Neck Cancer.

Case Medical Research ◽

10.31525/ct1-nct03998696 ◽

2019 ◽

Author(s):

Keyword(s):

Experimental Study ◽

Head And Neck Cancer ◽

Head And Neck ◽

Treatment Response ◽

Neck Cancer ◽

Locally Advanced ◽

Concurrent Chemoradiation ◽

Advanced Head ◽

Weekly Cisplatin

Download Full-text